NCT05705154

Brief Summary

Recruitment target: Phase I: Co-design of intervention: 5 to 15 CYP aged between 12-18 years of age referred to the pan-London long COVID MDT. Phase II: Randomised pilot: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. Methods: Phase I: Co-design Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022). Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. CYP will be randomised to receive either standard treatment or standard treatment plus intervention. Study Treatment Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and information. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from therapies and psychological services. Access to bite size videos and leaflets covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos. The leaflets and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. The bite size videos and live sessions are delivered by a clinical psychologist, a dietitian, specialist nurse, occupational therapist, and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required. Intervention Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention.:

  • Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
  • Identifying the connections between body and mind to address anxiety and breathlessness
  • Coping skills for managing anxiety using principles from narrative therapy and mindfulness
  • Online materials to improve self-efficacy with home practice
  • Social connection with other CYP for peer support, and resource sharing
  • Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 30, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

April 30, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

11 months

First QC Date

December 15, 2022

Last Update Submit

September 6, 2023

Conditions

Keywords

TeenagerAdolescent

Outcome Measures

Primary Outcomes (1)

  • Impact score of Strength and Difficulties (SDQ) questionnaire

    25 item questionnaire comprising of 5 scales of 5 items

    Through study completion, an average of 24 weeks

Secondary Outcomes (8)

  • Revised Childhood Anxiety and Depression Scale (RCADS) questionnaire

    Through study completion, an average of 24 weeks

  • EQ-5D-Y

    Through study completion, an average of 24 weeks

  • SF-36 Quality of Life

    Through study completion, an average of 24 weeks

  • 11 item Chandler Fatigue Questionnaire

    Through study completion, an average of 24 weeks

  • Visual Analogue Scale (VAS) Pain scale

    Through study completion, an average of 24 weeks

  • +3 more secondary outcomes

Study Arms (2)

Standard treatment

ACTIVE COMPARATOR

Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT OT and psychological services. Access to standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.

Behavioral: Psychology interventions

Intervention

EXPERIMENTAL

As above standard intervention plus the new co-designed intervention. Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.

Behavioral: Psychology interventions

Interventions

Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.

Also known as: breathing pattern retraining
InterventionStandard treatment

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.

You may not qualify if:

  • No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Brompton Hospital part of Guys and St Thomas' NHS Foundation Trust

London, Chelsea, SW3 6NP, United Kingdom

RECRUITING

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeAnxiety DisordersDyspnea

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersRespiration DisordersSigns and Symptoms, RespiratorySigns and Symptoms

Central Study Contacts

Samatha Sonnappa, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomised using block randomisation into either standard intervention arm or standard intervention plus the new co-designed intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2022

First Posted

January 30, 2023

Study Start

April 30, 2023

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

September 8, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

All data will be handled in accordance with the Data Protection Act (2018), National Health Service (NHS) Caldecott Principles, The United Kingdom Policy Framework for Health and Social Care Research, and the condition of the Research Ethics Committee (REC) approval. The Case Report Forms (CRFs) will not bear the subject's name or other personal identifiable data. The subject's study Identification Number (ID) will be used for identification. No data will be shared with any external organisation without appropriate consent and data sharing agreement in place, as applicable.

Locations